brequinar has been researched along with methylprednisolone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dunn, JF; Hart, M; Hatch, J; Li, S; Precht, A | 1 |
| Alexander, JW; Levy, AE | 1 |
1 trial(s) available for brequinar and methylprednisolone
| Article | Year |
|---|---|
Brequinar sodium significantly reduces the incidence of steroid-resistant rejection and resource utilization in primary renal transplant patients compared with azathioprine.
Topics: Acute Disease; Adolescent; Adult; Aged; Antilymphocyte Serum; Azathioprine; Biphenyl Compounds; Drug Resistance; Female; Graft Rejection; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Length of Stay; Male; Methylprednisolone; Middle Aged; Muromonab-CD3; Patient Readmission | 1996 |
1 other study(ies) available for brequinar and methylprednisolone
| Article | Year |
|---|---|
The significance of timing of additional short-term immunosuppression in the donor-specific transfusion/cyclosporine-treated rat.
Topics: Animals; Antilymphocyte Serum; Biphenyl Compounds; Blood Donors; Blood Transfusion; Cyclosporine; Drug Administration Schedule; Graft Rejection; Graft Survival; Heart Transplantation; Immunosuppressive Agents; Male; Methylprednisolone; Polyenes; Rats; Rats, Inbred ACI; Rats, Inbred Lew; Sirolimus; Time Factors | 1996 |